ReviewJournal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases2019

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety.

Paul Bird et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.